ConductScience.org, home

Trial · NCT05438888

Results by group14

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence Rate (Per 1,000 Participant-Year) of Composite of Stroke and Systemic Embolism (SE): Balanced CohortsWarfarin: Balanced Cohort75.22795% Confidence Interval 72.579 to 77.972Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Composite of Stroke and Systemic Embolism (SE): Balanced CohortsApixaban: Balanced Cohort55.80195% Confidence Interval 53.328 to 58.388Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Major Bleeding: Balanced CohortsWarfarin: Balanced Cohort25.32895% Confidence Interval 23.836 to 26.914Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Major Bleeding: Balanced CohortsApixaban: Balanced Cohort17.30695% Confidence Interval 15.973 to 18.751Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Cardiogenic Cerebral Embolism: Balanced CohortsWarfarin: Balanced Cohort21.38695% Confidence Interval 20.024 to 22.841Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Cardiogenic Cerebral Embolism: Balanced CohortsApixaban: Balanced Cohort13.47395% Confidence Interval 12.306 to 14.751Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Ischemic Stroke (Cerebral Infarction): Balanced CohortsWarfarin: Balanced Cohort39.60795% Confidence Interval 37.713 to 41.596Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Ischemic Stroke (Cerebral Infarction): Balanced CohortsApixaban: Balanced Cohort33.27995% Confidence Interval 31.395 to 35.277Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Intracranial Hemorrhage: Balanced CohortsWarfarin: Balanced Cohort20.78795% Confidence Interval 19.443 to 22.223Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Intracranial Hemorrhage: Balanced CohortsApixaban: Balanced Cohort13.13895% Confidence Interval 11.988 to 14.399Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Gastrointestinal Bleeding: Balanced CohortsWarfarin: Balanced Cohort42.64195% Confidence Interval 40.673 to 44.704Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Gastrointestinal Bleeding: Balanced CohortsApixaban: Balanced Cohort36.59595% Confidence Interval 34.610 to 38.695Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Intraocular Bleeding: Balanced CohortsWarfarin: Balanced Cohort4.22495% Confidence Interval 3.643 to 4.897Events Per 1000 Participant-Years
Incidence Rate (Per 1,000 Participant-Year) of Intraocular Bleeding: Balanced CohortsApixaban: Balanced Cohort2.68295% Confidence Interval 2.190 to 3.284Events Per 1000 Participant-Years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05438888/results